ST-segment elevation myocardial infarction in a patient with anomalous origin of left circumflex coronary artery

Masahiro Yamamoto, Hisao Ogawa(Kumamoto University Hospital), Kenichi Tsujita(Kumamoto University), Kenji Sakamoto(Kumamoto University), Tomoko Tanaka(Kumamoto University), Eiichiro Yamamoto(Sapporo Medical University), Seiji Hokimoto(Kumamoto University), Sunao Kojima(Kumamoto University), Sunao Nakamura(New Tokyo Hospital), Koichi Kaikita(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Naohiro Komura(Kumamoto University), Yasuhiro Izumiya(Kumamoto University), Kenshi Yamanaga(Kumamoto University)
Journal of Cardiology Cases
February 13, 2015
10.1016/j.jccase.2015.01.002
Cited by 3

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755